Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AGO2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Gene Symbol | AGO2 |
| Full Name | Argonaute-2 (EIF2C2) |
| Chromosome | 8q24.3 |
| Function | Primary mediator of miRNA-guided mRNA cleavage |
| Molecular Weight | 97 kDa |
| Amino Acids | 859 aa |
| Pathways | Blood-Brain Barrier, Complement, Microrna |
| UniProt ID | Q9UKV8 |
| NCBI Gene ID | 27185 |
| Ensembl ID | ENSG00000139318 |
| OMIM | 606228 |
| GeneCards | AGO2 |
| Human Protein Atlas | AGO2 |
| Associated Diseases | Aging, Senescence |
| Interactions | ALYREF, AMPK, AND, APOPTOSIS, BCL-2, CANCER |
| KG Connections | 114 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
AGO2["AGO2"] -->|"regulates"| STAT3["STAT3"]
style STAT3 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
AGO2["AGO2"] -.->|"inhibits"| Cancer["Cancer"]
style Cancer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AGO2["AGO2"] -.->|"inhibits"| Lymphoma["Lymphoma"]
style Lymphoma fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AGO2["AGO2"] -.->|"inhibits"| Ms["Ms"]
style Ms fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AGO2["AGO2"] -.->|"inhibits"| Tumor["Tumor"]
style Tumor fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AGO2["AGO2"] -->|"activates"| Als["Als"]
style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AGO2["AGO2"] -->|"activates"| Depression["Depression"]
style Depression fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
MIRNAS["MIRNAS"] -->|"associated"| AGO2["AGO2"]
style MIRNAS fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
TRF33["TRF33"] -->|"interacts"| AGO2["AGO2"]
style TRF33 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
STAT3_1["STAT3"] -->|"regulates"| AGO2["AGO2"]
style STAT3_1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
BCL_2["BCL-2"] -.->|"inhibits"| AGO2["AGO2"]
style BCL_2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
TP53["TP53"] -->|"regulates"| AGO2["AGO2"]
style TP53 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style AGO2 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| STAT3 | regulates | protein | 0.70 |
| PTEN | activates | gene | 0.70 |
| Tumor | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Lymphoma | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Breast Cancer | therapeutic_target | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| CANCER | regulates | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Cardiomyopathy | activates | disease | 0.65 |
| Gastric Cancer | inhibits | disease | 0.65 |
| Senescence | therapeutic_target | disease | 0.65 |
| CANCER | interacts_with | gene | 0.60 |
| MICRORNAS | activates | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| Cardiomyocyte | inhibits | cell_type | 0.60 |
| App | therapeutic_target | protein | 0.60 |
| LIN28B | interacts_with | gene | 0.60 |
| EXOSOMES | therapeutic_target | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| MIRNAS | inhibits | gene | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| ALYREF | activates | gene | 0.60 |
| CANCER | stabilizes | disease | 0.60 |
| AMPK | activates | gene | 0.60 |
| Cell Cycle | inhibits | pathway | 0.60 |
| CDKN1A | inhibits | gene | 0.60 |
| Apoptosis | inhibits | pathway | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| CCNG2 | inhibits | gene | 0.60 |
| Metalloproteinase | inhibits | protein | 0.60 |
| Ras | inhibits | protein | 0.60 |
| CAV1 | interacts_with | gene | 0.60 |
| Blood-Brain Barrier | regulates | pathway | 0.60 |
| Microrna | regulates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MIRNAS | associated_with | gene | 0.70 |
| TRF33 | interacts_with | gene | 0.64 |
| CAV1 | interacts_with | gene | 0.60 |
| STAT3 | inhibits | gene | 0.60 |
| MIRNAS | activates | gene | 0.60 |
| MICRORNAS | activates | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| MIR-302B | inhibits | gene | 0.60 |
| CDKN1A | inhibits | gene | 0.60 |
| GALNT3 | inhibits | gene | 0.60 |
| STAT3 | regulates | gene | 0.60 |
| MICRORNAS | regulates | gene | 0.60 |
| MIRNAS | inhibits | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| HDAC6 | activates | gene | 0.60 |
| EXOSOMES | therapeutic_target | gene | 0.60 |
| CCNG2 | inhibits | gene | 0.60 |
| TP53 | regulates | gene | 0.60 |
| BCL-2 | inhibits | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| EXOSOMES | associated_with | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| CANCER | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AGO2 in their description or question text
No additional research found